Amy Huebschmann
Concepts (295)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exercise | 17 | 2026 | 2213 | 2.160 |
Why?
| | Diabetes Mellitus, Type 2 | 17 | 2023 | 2623 | 1.730 |
Why?
| | Primary Health Care | 17 | 2026 | 1776 | 1.680 |
Why?
| | Cancer Survivors | 5 | 2026 | 348 | 1.680 |
Why?
| | School Health Services | 4 | 2024 | 218 | 1.680 |
Why?
| | Asthma | 5 | 2024 | 1800 | 1.480 |
Why?
| | Community-Based Participatory Research | 2 | 2025 | 172 | 0.980 |
Why?
| | Qualitative Research | 9 | 2026 | 1734 | 0.980 |
Why?
| | Mass Screening | 7 | 2026 | 1307 | 0.940 |
Why?
| | Contraception | 2 | 2021 | 170 | 0.930 |
Why?
| | Harm Reduction | 1 | 2025 | 49 | 0.870 |
Why?
| | Health Equity | 2 | 2025 | 139 | 0.860 |
Why?
| | Midwifery | 1 | 2026 | 70 | 0.850 |
Why?
| | Community-Institutional Relations | 1 | 2025 | 101 | 0.830 |
Why?
| | Community Participation | 1 | 2025 | 128 | 0.820 |
Why?
| | Telemedicine | 3 | 2025 | 966 | 0.790 |
Why?
| | Chest Pain | 1 | 2024 | 100 | 0.780 |
Why?
| | School Nursing | 1 | 2024 | 34 | 0.780 |
Why?
| | Program Development | 1 | 2025 | 371 | 0.770 |
Why?
| | Diabetes Mellitus | 5 | 2020 | 1101 | 0.760 |
Why?
| | Humans | 80 | 2026 | 146342 | 0.720 |
Why?
| | Motivation | 2 | 2018 | 605 | 0.710 |
Why?
| | Exercise Therapy | 2 | 2026 | 488 | 0.690 |
Why?
| | Hospice Care | 1 | 2025 | 230 | 0.680 |
Why?
| | Cardiovascular Diseases | 5 | 2023 | 2219 | 0.670 |
Why?
| | Mentoring | 3 | 2026 | 166 | 0.670 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1763 | 0.640 |
Why?
| | Breast Neoplasms | 4 | 2026 | 2418 | 0.620 |
Why?
| | Referral and Consultation | 2 | 2026 | 881 | 0.610 |
Why?
| | Couples Therapy | 1 | 2019 | 12 | 0.600 |
Why?
| | Self-Management | 2 | 2019 | 207 | 0.600 |
Why?
| | Female | 47 | 2026 | 79499 | 0.600 |
Why?
| | Early Detection of Cancer | 1 | 2025 | 506 | 0.600 |
Why?
| | Counseling | 2 | 2014 | 406 | 0.590 |
Why?
| | Research Design | 4 | 2022 | 1143 | 0.590 |
Why?
| | Aged | 27 | 2026 | 26432 | 0.570 |
Why?
| | Health Behavior | 4 | 2024 | 802 | 0.550 |
Why?
| | Peer Group | 3 | 2026 | 251 | 0.550 |
Why?
| | Postpartum Period | 1 | 2021 | 377 | 0.540 |
Why?
| | Information Dissemination | 2 | 2023 | 226 | 0.520 |
Why?
| | Health Promotion | 4 | 2025 | 786 | 0.510 |
Why?
| | Interviews as Topic | 5 | 2026 | 930 | 0.500 |
Why?
| | Sex Factors | 5 | 2024 | 2107 | 0.490 |
Why?
| | Substance-Related Disorders | 1 | 2025 | 1100 | 0.470 |
Why?
| | Reproducibility of Results | 3 | 2025 | 3416 | 0.460 |
Why?
| | Hair | 1 | 2015 | 81 | 0.440 |
Why?
| | Male | 36 | 2026 | 73396 | 0.440 |
Why?
| | Surveys and Questionnaires | 11 | 2025 | 6073 | 0.420 |
Why?
| | Patients | 3 | 2020 | 183 | 0.410 |
Why?
| | Program Evaluation | 4 | 2026 | 952 | 0.410 |
Why?
| | Athletes | 1 | 2018 | 432 | 0.410 |
Why?
| | Middle Aged | 28 | 2026 | 36619 | 0.400 |
Why?
| | Social Determinants of Health | 4 | 2024 | 317 | 0.400 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2025 | 1408 | 0.390 |
Why?
| | Caregivers | 5 | 2024 | 1080 | 0.380 |
Why?
| | Professional-Patient Relations | 2 | 2012 | 146 | 0.380 |
Why?
| | Biomarkers | 1 | 2024 | 4340 | 0.370 |
Why?
| | Needs Assessment | 3 | 2024 | 404 | 0.370 |
Why?
| | Delivery of Health Care | 5 | 2022 | 947 | 0.370 |
Why?
| | Colorado | 8 | 2025 | 4595 | 0.360 |
Why?
| | Hypertension | 4 | 2022 | 1272 | 0.360 |
Why?
| | Healthcare Disparities | 2 | 2025 | 733 | 0.360 |
Why?
| | Biomedical Research | 1 | 2019 | 729 | 0.350 |
Why?
| | Lung Neoplasms | 1 | 2025 | 2675 | 0.340 |
Why?
| | Aging, Premature | 1 | 2011 | 18 | 0.340 |
Why?
| | Home Care Services | 2 | 2025 | 293 | 0.330 |
Why?
| | Pragmatic Clinical Trials as Topic | 2 | 2024 | 135 | 0.330 |
Why?
| | Critical Pathways | 1 | 2012 | 104 | 0.320 |
Why?
| | Neoplasms | 1 | 2026 | 2954 | 0.310 |
Why?
| | Decision Support Systems, Clinical | 2 | 2025 | 279 | 0.310 |
Why?
| | Patient Preference | 2 | 2024 | 226 | 0.310 |
Why?
| | Dietary Fats | 1 | 2012 | 307 | 0.300 |
Why?
| | Adult | 26 | 2026 | 41087 | 0.290 |
Why?
| | Health Personnel | 3 | 2025 | 754 | 0.280 |
Why?
| | Perception | 2 | 2024 | 373 | 0.280 |
Why?
| | Disease Management | 2 | 2015 | 651 | 0.280 |
Why?
| | United States | 12 | 2026 | 16136 | 0.280 |
Why?
| | Occupational Health | 2 | 2022 | 212 | 0.280 |
Why?
| | Physical Exertion | 1 | 2009 | 204 | 0.280 |
Why?
| | Internet | 4 | 2026 | 660 | 0.280 |
Why?
| | Medicare | 4 | 2022 | 920 | 0.270 |
Why?
| | Feasibility Studies | 3 | 2022 | 1135 | 0.270 |
Why?
| | Diabetic Angiopathies | 3 | 2017 | 265 | 0.270 |
Why?
| | Fear | 1 | 2011 | 373 | 0.260 |
Why?
| | Practice Patterns, Physicians' | 2 | 2014 | 1408 | 0.260 |
Why?
| | Palliative Care | 3 | 2025 | 1032 | 0.250 |
Why?
| | Attitude of Health Personnel | 2 | 2024 | 1219 | 0.250 |
Why?
| | Heart Failure | 4 | 2025 | 2329 | 0.250 |
Why?
| | Patient Acceptance of Health Care | 2 | 2025 | 881 | 0.230 |
Why?
| | Electronic Health Records | 3 | 2025 | 1210 | 0.230 |
Why?
| | Social Support | 3 | 2024 | 646 | 0.230 |
Why?
| | Vascular Stiffness | 2 | 2023 | 488 | 0.220 |
Why?
| | Glycation End Products, Advanced | 1 | 2006 | 84 | 0.220 |
Why?
| | Physicians | 3 | 2023 | 955 | 0.220 |
Why?
| | Chronic Disease | 4 | 2024 | 1827 | 0.220 |
Why?
| | Adolescent | 10 | 2024 | 22557 | 0.210 |
Why?
| | Troponin | 1 | 2024 | 50 | 0.210 |
Why?
| | Delirium | 1 | 2026 | 107 | 0.210 |
Why?
| | Troponin T | 1 | 2024 | 63 | 0.210 |
Why?
| | Point-of-Care Systems | 2 | 2020 | 185 | 0.210 |
Why?
| | Aged, 80 and over | 4 | 2025 | 8391 | 0.200 |
Why?
| | Troponin I | 1 | 2024 | 74 | 0.200 |
Why?
| | Narration | 1 | 2024 | 82 | 0.200 |
Why?
| | Transportation | 1 | 2024 | 54 | 0.200 |
Why?
| | Social Isolation | 1 | 2024 | 73 | 0.190 |
Why?
| | Vulnerable Populations | 1 | 2024 | 178 | 0.190 |
Why?
| | Cost-Benefit Analysis | 1 | 2026 | 640 | 0.180 |
Why?
| | Pilot Projects | 4 | 2025 | 1888 | 0.180 |
Why?
| | Oxygen | 2 | 2018 | 997 | 0.180 |
Why?
| | Mental Health | 3 | 2024 | 779 | 0.180 |
Why?
| | Cross-Sectional Studies | 8 | 2021 | 5899 | 0.170 |
Why?
| | Advance Care Planning | 1 | 2025 | 244 | 0.170 |
Why?
| | Leg | 2 | 2021 | 246 | 0.170 |
Why?
| | Patient Care Team | 3 | 2025 | 701 | 0.170 |
Why?
| | Hospice and Palliative Care Nursing | 1 | 2023 | 115 | 0.170 |
Why?
| | Government Programs | 1 | 2021 | 27 | 0.170 |
Why?
| | Mental Health Services | 2 | 2025 | 450 | 0.170 |
Why?
| | Health Care Surveys | 2 | 2014 | 541 | 0.170 |
Why?
| | Psychometrics | 1 | 2025 | 712 | 0.160 |
Why?
| | Child | 9 | 2024 | 22693 | 0.160 |
Why?
| | Contraceptive Agents | 1 | 2021 | 65 | 0.160 |
Why?
| | Oxygen Consumption | 6 | 2021 | 721 | 0.160 |
Why?
| | Oxidative Phosphorylation | 2 | 2019 | 212 | 0.160 |
Why?
| | Ambulatory Care | 1 | 2025 | 628 | 0.160 |
Why?
| | Multiple Chronic Conditions | 1 | 2020 | 34 | 0.160 |
Why?
| | Guatemala | 1 | 2021 | 349 | 0.150 |
Why?
| | Influenza Vaccines | 1 | 2024 | 544 | 0.150 |
Why?
| | Social Welfare | 1 | 2019 | 26 | 0.150 |
Why?
| | Community Mental Health Services | 1 | 2020 | 85 | 0.150 |
Why?
| | Precision Medicine | 1 | 2024 | 462 | 0.150 |
Why?
| | Social Work | 1 | 2020 | 84 | 0.150 |
Why?
| | Patient Navigation | 1 | 2022 | 126 | 0.150 |
Why?
| | Psychosocial Support Systems | 1 | 2019 | 17 | 0.150 |
Why?
| | Sitagliptin Phosphate | 1 | 2019 | 31 | 0.150 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 481 | 0.150 |
Why?
| | Intimate Partner Violence | 1 | 2021 | 93 | 0.150 |
Why?
| | Socioeconomic Factors | 2 | 2015 | 1327 | 0.140 |
Why?
| | Schools | 1 | 2022 | 436 | 0.140 |
Why?
| | Dementia | 1 | 2023 | 324 | 0.140 |
Why?
| | Diastole | 1 | 2019 | 147 | 0.140 |
Why?
| | Patient Care Planning | 1 | 2020 | 170 | 0.140 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 46 | 0.140 |
Why?
| | Accelerometry | 1 | 2019 | 124 | 0.140 |
Why?
| | Inpatients | 1 | 2023 | 540 | 0.140 |
Why?
| | Cardiorespiratory Fitness | 1 | 2019 | 73 | 0.140 |
Why?
| | Influenza, Human | 1 | 2024 | 640 | 0.140 |
Why?
| | Quality of Life | 3 | 2026 | 3200 | 0.140 |
Why?
| | Cardiovascular System | 1 | 2019 | 137 | 0.130 |
Why?
| | Exercise Tolerance | 2 | 2017 | 289 | 0.130 |
Why?
| | Cultural Characteristics | 1 | 2018 | 65 | 0.130 |
Why?
| | Quality Improvement | 2 | 2026 | 1354 | 0.130 |
Why?
| | Focus Groups | 2 | 2023 | 588 | 0.130 |
Why?
| | Emergency Service, Hospital | 3 | 2026 | 2363 | 0.130 |
Why?
| | Checklist | 1 | 2018 | 105 | 0.130 |
Why?
| | Clinical Competence | 1 | 2025 | 1272 | 0.130 |
Why?
| | Health Care Costs | 1 | 2020 | 423 | 0.120 |
Why?
| | Venoms | 1 | 2016 | 22 | 0.120 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 125 | 0.120 |
Why?
| | Patient Satisfaction | 2 | 2019 | 706 | 0.120 |
Why?
| | Ultrasonography | 1 | 2020 | 788 | 0.120 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2016 | 34 | 0.120 |
Why?
| | Health Services Accessibility | 2 | 2024 | 1107 | 0.120 |
Why?
| | Hypoglycemic Agents | 3 | 2019 | 1412 | 0.120 |
Why?
| | Research Personnel | 1 | 2018 | 190 | 0.120 |
Why?
| | Vaccination | 1 | 2024 | 1449 | 0.120 |
Why?
| | Microvessels | 1 | 2017 | 98 | 0.120 |
Why?
| | Blood Vessels | 1 | 2017 | 164 | 0.110 |
Why?
| | Self Efficacy | 1 | 2019 | 418 | 0.110 |
Why?
| | Muscle, Skeletal | 4 | 2021 | 1818 | 0.110 |
Why?
| | Lung Diseases | 1 | 2022 | 787 | 0.110 |
Why?
| | Sex Characteristics | 2 | 2022 | 801 | 0.110 |
Why?
| | Pregnancy | 2 | 2026 | 7230 | 0.100 |
Why?
| | American Heart Association | 1 | 2015 | 364 | 0.100 |
Why?
| | Risk Factors | 3 | 2020 | 10921 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2016 | 391 | 0.100 |
Why?
| | Faculty | 1 | 2014 | 152 | 0.090 |
Why?
| | Interprofessional Relations | 1 | 2015 | 275 | 0.090 |
Why?
| | Pandemics | 1 | 2021 | 1707 | 0.090 |
Why?
| | Attitude to Health | 1 | 2015 | 421 | 0.090 |
Why?
| | Incidence | 1 | 2019 | 2936 | 0.090 |
Why?
| | Prevalence | 1 | 2019 | 2861 | 0.090 |
Why?
| | Prospective Studies | 3 | 2021 | 8123 | 0.090 |
Why?
| | Pharmacists | 1 | 2015 | 260 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2015 | 471 | 0.090 |
Why?
| | Women's Health | 1 | 2014 | 317 | 0.090 |
Why?
| | Age Factors | 2 | 2025 | 3347 | 0.080 |
Why?
| | Internal Medicine | 1 | 2014 | 280 | 0.080 |
Why?
| | Stroke Volume | 2 | 2025 | 652 | 0.080 |
Why?
| | Dietary Carbohydrates | 1 | 2012 | 146 | 0.080 |
Why?
| | Exercise Test | 2 | 2015 | 637 | 0.080 |
Why?
| | Psychotherapy | 1 | 2012 | 183 | 0.080 |
Why?
| | Peptides | 1 | 2016 | 992 | 0.080 |
Why?
| | Antidepressive Agents | 1 | 2012 | 235 | 0.080 |
Why?
| | Plant Preparations | 1 | 2010 | 37 | 0.080 |
Why?
| | Health Expenditures | 1 | 2012 | 198 | 0.080 |
Why?
| | Nonprescription Drugs | 1 | 2010 | 68 | 0.070 |
Why?
| | Depressive Disorder | 1 | 2012 | 361 | 0.070 |
Why?
| | Pulse Wave Analysis | 2 | 2023 | 268 | 0.070 |
Why?
| | Workplace | 2 | 2022 | 268 | 0.070 |
Why?
| | Comparative Effectiveness Research | 1 | 2010 | 171 | 0.070 |
Why?
| | Patient Education as Topic | 1 | 2014 | 770 | 0.070 |
Why?
| | Obesity | 2 | 2023 | 3131 | 0.070 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 519 | 0.070 |
Why?
| | Patient Compliance | 1 | 2012 | 589 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2022 | 0.060 |
Why?
| | Prejudice | 1 | 2007 | 60 | 0.060 |
Why?
| | Guideline Adherence | 1 | 2012 | 594 | 0.060 |
Why?
| | Disclosure | 1 | 2007 | 91 | 0.060 |
Why?
| | Diabetes, Gestational | 1 | 2011 | 307 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2016 | 5439 | 0.060 |
Why?
| | Walking | 1 | 2011 | 546 | 0.060 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2006 | 36 | 0.060 |
Why?
| | Nebraska | 1 | 2025 | 21 | 0.060 |
Why?
| | Wyoming | 1 | 2025 | 27 | 0.060 |
Why?
| | Quality-Adjusted Life Years | 1 | 2026 | 122 | 0.060 |
Why?
| | Medicaid | 2 | 2019 | 477 | 0.060 |
Why?
| | Hypoglycemia | 1 | 2010 | 490 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2006 | 210 | 0.050 |
Why?
| | Mothers | 1 | 2011 | 772 | 0.050 |
Why?
| | Regional Blood Flow | 2 | 2017 | 507 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2025 | 417 | 0.050 |
Why?
| | Safety-net Providers | 1 | 2024 | 133 | 0.050 |
Why?
| | Internship and Residency | 1 | 2014 | 1281 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2019 | 2070 | 0.050 |
Why?
| | Language | 1 | 2025 | 315 | 0.050 |
Why?
| | Delphi Technique | 1 | 2024 | 350 | 0.040 |
Why?
| | Cardiology | 1 | 2025 | 363 | 0.040 |
Why?
| | Patient Care | 1 | 2023 | 120 | 0.040 |
Why?
| | Longevity | 1 | 2022 | 179 | 0.040 |
Why?
| | Small Business | 1 | 2021 | 51 | 0.040 |
Why?
| | Aorta, Thoracic | 1 | 2023 | 284 | 0.040 |
Why?
| | Point-of-Care Testing | 1 | 2020 | 36 | 0.040 |
Why?
| | Aging | 1 | 2011 | 1996 | 0.040 |
Why?
| | Consensus | 1 | 2021 | 467 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 597 | 0.040 |
Why?
| | Sulfonylurea Compounds | 1 | 2019 | 49 | 0.040 |
Why?
| | Placebos | 1 | 2019 | 192 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1761 | 0.040 |
Why?
| | Self Care | 1 | 2022 | 396 | 0.040 |
Why?
| | Goals | 1 | 2020 | 187 | 0.030 |
Why?
| | Overweight | 1 | 2023 | 614 | 0.030 |
Why?
| | Poverty | 1 | 2022 | 530 | 0.030 |
Why?
| | Young Adult | 2 | 2012 | 14330 | 0.030 |
Why?
| | Cell Respiration | 1 | 2018 | 104 | 0.030 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 96 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2022 | 568 | 0.030 |
Why?
| | Capillary Resistance | 1 | 2017 | 4 | 0.030 |
Why?
| | Oxyhemoglobins | 1 | 2017 | 28 | 0.030 |
Why?
| | Publishing | 1 | 2018 | 117 | 0.030 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2017 | 70 | 0.030 |
Why?
| | Cognition | 1 | 2025 | 1292 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2012 | 11821 | 0.030 |
Why?
| | Microcirculation | 1 | 2017 | 142 | 0.030 |
Why?
| | Bicycling | 1 | 2017 | 117 | 0.030 |
Why?
| | Health Status | 1 | 2021 | 827 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2017 | 365 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2025 | 17438 | 0.030 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2016 | 150 | 0.030 |
Why?
| | Parents | 1 | 2024 | 1394 | 0.030 |
Why?
| | Communication | 1 | 2022 | 980 | 0.030 |
Why?
| | Infant | 2 | 2024 | 10114 | 0.030 |
Why?
| | Ventricular Function | 1 | 2015 | 53 | 0.030 |
Why?
| | Arteries | 1 | 2016 | 261 | 0.030 |
Why?
| | Hemoglobins | 1 | 2017 | 384 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1148 | 0.030 |
Why?
| | Endothelium | 1 | 2015 | 119 | 0.030 |
Why?
| | Blood Pressure | 1 | 2021 | 1765 | 0.030 |
Why?
| | Forearm | 1 | 2015 | 141 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2015 | 218 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 117 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1369 | 0.030 |
Why?
| | Child, Preschool | 2 | 2024 | 11913 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2021 | 3017 | 0.020 |
Why?
| | Brachial Artery | 1 | 2015 | 207 | 0.020 |
Why?
| | Reaction Time | 1 | 2015 | 438 | 0.020 |
Why?
| | Lung Diseases, Obstructive | 1 | 2012 | 43 | 0.020 |
Why?
| | Pediatrics | 1 | 2020 | 1124 | 0.020 |
Why?
| | Vasodilation | 1 | 2015 | 519 | 0.020 |
Why?
| | Kinetics | 1 | 2015 | 1553 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2016 | 762 | 0.020 |
Why?
| | Mexico | 1 | 2011 | 233 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3712 | 0.020 |
Why?
| | Computer Communication Networks | 1 | 2010 | 30 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2016 | 952 | 0.020 |
Why?
| | Blood Glucose | 1 | 2019 | 2360 | 0.020 |
Why?
| | Emigrants and Immigrants | 1 | 2011 | 160 | 0.020 |
Why?
| | Comorbidity | 1 | 2012 | 1665 | 0.020 |
Why?
| | Homosexuality, Female | 1 | 2007 | 41 | 0.020 |
Why?
| | Public Opinion | 1 | 2007 | 61 | 0.020 |
Why?
| | Logistic Models | 1 | 2012 | 2126 | 0.020 |
Why?
| | Data Collection | 1 | 2010 | 650 | 0.020 |
Why?
| | Models, Statistical | 1 | 2011 | 669 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2015 | 1247 | 0.010 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 751 | 0.010 |
Why?
| | Homosexuality, Male | 1 | 2007 | 231 | 0.010 |
Why?
|
|
Huebschmann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|